| Scott Lake, OD | |
|
5707 W Northern Ave Ste 106, Glendale, AZ 85301-1355 | |
| (602) 512-3299 | |
| Not Available |
| Full Name | Scott Lake |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 16 Years |
| Location | 5707 W Northern Ave Ste 106, Glendale, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154587822 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 002756 (Connecticut) | Secondary |
| 152W00000X | Optometrist | 2519 (Arizona) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nationwide Optometry P.c. | 6901033075 | 41 |
News Archive
Medical College of Wisconsin Cancer Center researchers in Milwaukee have learned that a protein, CXCL12, that normally controls intestinal cell movement, has the potential to halt colorectal cancer spreading.
Arrayit Corporation (OTCBB: ARYC), a proprietary life sciences technology leader, announces that on August 31st, 2009 the company received a patent certificate from the most populous country on the planet, the People's Republic of China. The patent covers Dr. Mark Schena's microarray methods of genotyping multiple patient samples, commonly referred to as Arrayit's "Variation Identification Platform™" (VIP) technology.
The study, performed at the University of California-San Francisco, of 58 breast cancer patients found that the best way to predict a patient's recurrence-free survival is to review the initial MR examination (before the patient has chemotherapy) and the final MR examination (after chemotherapy has been completed).
The body's repair mechanisms begin to fail with increasing age. As a result, signs of wear and tear appear and the risk for many diseases, including Alzheimer's disease, diabetes, cardiovascular disorders and cancer, increases.
Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) to update the current label of XELJANZ® (tofacitinib citrate) 5 mg tablets to include radiographic data from two Phase 3 studies, ORAL Scan (A3921044) and ORAL Start.
› Verified 3 days ago
| Provider Name | Nationwide Optometry P.c. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1326472945 PECOS PAC ID: 6901033075 Enrollment ID: O20131217000251 |
News Archive
Medical College of Wisconsin Cancer Center researchers in Milwaukee have learned that a protein, CXCL12, that normally controls intestinal cell movement, has the potential to halt colorectal cancer spreading.
Arrayit Corporation (OTCBB: ARYC), a proprietary life sciences technology leader, announces that on August 31st, 2009 the company received a patent certificate from the most populous country on the planet, the People's Republic of China. The patent covers Dr. Mark Schena's microarray methods of genotyping multiple patient samples, commonly referred to as Arrayit's "Variation Identification Platform™" (VIP) technology.
The study, performed at the University of California-San Francisco, of 58 breast cancer patients found that the best way to predict a patient's recurrence-free survival is to review the initial MR examination (before the patient has chemotherapy) and the final MR examination (after chemotherapy has been completed).
The body's repair mechanisms begin to fail with increasing age. As a result, signs of wear and tear appear and the risk for many diseases, including Alzheimer's disease, diabetes, cardiovascular disorders and cancer, increases.
Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) to update the current label of XELJANZ® (tofacitinib citrate) 5 mg tablets to include radiographic data from two Phase 3 studies, ORAL Scan (A3921044) and ORAL Start.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Scott Lake, OD 220 N Mckemy Ave, Chandler, AZ 85226-2651 Ph: (480) 961-1865 | Scott Lake, OD 5707 W Northern Ave Ste 106, Glendale, AZ 85301-1355 Ph: (602) 512-3299 |
News Archive
Medical College of Wisconsin Cancer Center researchers in Milwaukee have learned that a protein, CXCL12, that normally controls intestinal cell movement, has the potential to halt colorectal cancer spreading.
Arrayit Corporation (OTCBB: ARYC), a proprietary life sciences technology leader, announces that on August 31st, 2009 the company received a patent certificate from the most populous country on the planet, the People's Republic of China. The patent covers Dr. Mark Schena's microarray methods of genotyping multiple patient samples, commonly referred to as Arrayit's "Variation Identification Platform™" (VIP) technology.
The study, performed at the University of California-San Francisco, of 58 breast cancer patients found that the best way to predict a patient's recurrence-free survival is to review the initial MR examination (before the patient has chemotherapy) and the final MR examination (after chemotherapy has been completed).
The body's repair mechanisms begin to fail with increasing age. As a result, signs of wear and tear appear and the risk for many diseases, including Alzheimer's disease, diabetes, cardiovascular disorders and cancer, increases.
Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) to update the current label of XELJANZ® (tofacitinib citrate) 5 mg tablets to include radiographic data from two Phase 3 studies, ORAL Scan (A3921044) and ORAL Start.
› Verified 3 days ago
Dr. Margarita Alicia Coca, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 7700 W Arrowhead Towne Ctr, Glendale, AZ 85308 Phone: 623-486-2020 | |
Dr. Diana Vega Hernandez, OD Optometrist Medicare: May Accept Medicare Assignments Practice Location: 7260 W Bell Rd, Glendale, AZ 85308 Phone: 623-486-1888 Fax: 623-486-8001 | |
Michael L Berger Od Pc Optometrist Medicare: Medicare Enrolled Practice Location: 6677 W Thunderbird Rd #b132, Glendale, AZ 85306 Phone: 602-978-1199 | |
Stacie L Westen Od Pllc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5605 W Northern Ave, Glendale, AZ 85301 Phone: 623-934-6917 | |
Jessica Chow, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5707 W Northern Ave, Suite 106, Glendale, AZ 85301 Phone: 602-512-3299 Fax: 602-512-3303 | |
Florencia Yeh, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 5865 W Utopia Rd, Glendale, AZ 85308 Phone: 623-806-7265 | |
Krissa Janae Lindsay, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 17550 N 79th Ave, Glendale, AZ 85308 Phone: 623-776-4006 |